Objective: Practical scales with tested validity and reliability are needed to clinically determine frailty.The aim of this study is to find out whether the Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight (FRAIL) Scale is an effective screening scale to show frailty. Patients and Methods: The Frail non-Disabled (FIND) scale validated in the Turkish population was applied for FRAIL Scale validation. Comprehensive geriatric assessment and Fried Index were performed on 85 outpatients who were 65 years and older. The patients were examined in terms of comorbidity, number of falls, living environment, number of drugs used, and hospitalization in the last year. Results: The FRAIL Scale had a high correlation with the FIND scale and Fried Index (correlation coefficients are 0.956 and 0.934, respectively). In addition, it was found to be associated with Activities of Daily Living (ADL), Instrumental Activities of Daily Living (IADL) scales, the Mini-Mental State Examination (MMSE),Y esavage Geriatric Depression Scale (GDS), Mini Nutritional Assessment short-form (MNA-sf),Clock Drawing Test (CDT), handgrip strength, and timed up and go test (p<0.05). The compliance between independent practitioners and test-retest compliance were found to be 100% (full compliance,Cronbach’s alpha coefficient is 1.00). Conclusion: In the Turkish geriatric population, the FRAIL Scale was found to be a reliable and valid scale in showing frailty.
1 August 2018 in International Journal of Antimicrobial Agents
Background: A novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) occurred in China in December 2019 and has spread globally. In this study, we aimed to describe the clinical characteristics and outcomes of hospitalized older adults with coronavirus disease 2019 (COVID-19) in Turkey. Methods: We retrospectively analyzed the clinical data of hospitalized patients aged ≥ 60 years with confirmed COVID-19 from March 11, 2020 to May 27, 2020 using nationwide health database. Results: In this nationwide cohort, a total of 16,942 hospitalized older adults with COVID-19 were enrolled, of whom 8,635 (51%) were women. Mean age was 71.2 ± 8.5 years, ranging from 60 to 113 years. Mortality rate before and after curfew was statistically different (32.2% vs. 17.9%; p < .001, respectively). Through multivariate analysis of the causes of death in older patients, we found that male gender, diabetes mellitus, heart failure, dementia, were all significantly associated with mortality in entire cohort. In addition to abovementioned risk factors, in patients aged between 60 and 79 years, hypertension, chronic kidney disease and cancer and in patients 80 years of age and older malnutrition were also associated with increased risk of mortality. Conclusions: In addition to the results of previous studies with smaller sample size, our results confirmed the age-related relationship between specific comorbidities and COVID-19–related mortality.